# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-097443
Filing Date
2024-11-13
Accepted
2024-11-13 16:01:47
Documents
79
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0216929-10q_oruka.htm iXBRL | 10-Q | 1145413
2 | FORM OF REGISTRATION RIGHTS AGREEMENT, DATED AS OF AUGUST 29, 2024 | ea021692901ex10-4_oruka.htm | EX-10.4 | 100073
3 | CERTIFICATION | ea021692901ex31-1_oruka.htm | EX-31.1 | 9877
4 | CERTIFICATION | ea021692901ex31-2_oruka.htm | EX-31.2 | 9911
5 | CERTIFICATION | ea021692901ex32-1_oruka.htm | EX-32.1 | 6486
| Complete submission text file | 0001213900-24-097443.txt |  | 6241428

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | orka-20240930.xsd | EX-101.SCH | 67909
7 | XBRL CALCULATION FILE | orka-20240930_cal.xml | EX-101.CAL | 32124
8 | XBRL DEFINITION FILE | orka-20240930_def.xml | EX-101.DEF | 326847
9 | XBRL LABEL FILE | orka-20240930_lab.xml | EX-101.LAB | 550245
10 | XBRL PRESENTATION FILE | orka-20240930_pre.xml | EX-101.PRE | 336811
81 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0216929-10q_oruka_htm.xml | XML | 580186

Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 241453876
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)